Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
AstraZeneca
Daiichi Sankyo
Colorcon
Cantor Fitzgerald
Healthtrust
Fuji
Julphar

Generated: November 20, 2018

DrugPatentWatch Database Preview

CARDIOTEC Drug Profile

« Back to Dashboard

Which patents cover Cardiotec, and when can generic versions of Cardiotec launch?

Cardiotec is a drug marketed by Bracco and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in CARDIOTEC is technetium tc-99m teboroxime kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m teboroxime kit profile page.

Summary for CARDIOTEC
US Patents:1
Applicants:1
NDAs:1
DailyMed Link:CARDIOTEC at DailyMed
Drug patent expirations by year for CARDIOTEC
Generic Entry Opportunity Date for CARDIOTEC
Generic Entry Date for CARDIOTEC*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
INJECTABLE;INJECTION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for CARDIOTEC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco CARDIOTEC technetium tc-99m teboroxime kit INJECTABLE;INJECTION 019928-001 Dec 19, 1990 DISCN No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for CARDIOTEC

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0736 Netherlands ➤ Sign Up PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
AstraZeneca
Daiichi Sankyo
Colorcon
Cantor Fitzgerald
Healthtrust
Fuji
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.